Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | BMY | GILD | VRTX |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 244.63 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 244.64 | 264.80 | 57.66 | 93.52 | 405.93 |
| Low | 237.12 | 260.87 | 56.80 | 91.79 | 390.92 |
| Last | 242.26 | 264.00 | 57.58 | 93.40 | 405.27 |
| Change | -3.18 | +0.62 | +0.25 | +0.83 | +8.00 |
| % Change | -1.30% | +0.24% | +0.44% | +0.90% | +2.01% |
| Volume | 718,000 | 3,025,700 | 9,431,900 | 4,809,500 | 2,204,400 |
| 20-Day Average Volume | 681,000 | 5,159,455 | 11,914,005 | 7,605,575 | 1,867,665 |
| Previous Close | 245.44 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 249.42 | 273.49 | 57.92 | 92.13 | 454.68 |
| 20-Day Raw Stochastic | 35.82% | 24.31% | 45.04% | 77.27% | 27.81% |
| 20-Day Relative Strength | 41.72% | 32.92% | 53.40% | 56.96% | 32.75% |
| Weighted Alpha | +5.59 | -14.82 | +19.99 | +25.07 | -8.79 |
| Today's Opinion | 24% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 8% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 8% Buy | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.71% since 12/16/24 | -0.94% since 12/16/24 | +3.06% since 12/16/24 | +1.47% since 12/16/24 | -13.42% since 12/16/24 |
| Low | 233.41 on 12/19/24 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 249.58 on 12/17/24 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | -1.07% since 11/22/24 | -10.37% since 11/22/24 | -2.19% since 11/22/24 | +3.56% since 11/22/24 | -10.13% since 11/22/24 |
| Low | 233.41 on 12/19/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 258.12 on 12/09/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -10.88% since 09/23/24 | -21.34% since 09/23/24 | +15.14% since 09/23/24 | +11.20% since 09/23/24 | -11.90% since 09/23/24 |
| Low | 229.85 on 11/18/24 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 304.39 on 10/17/24 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +46.20% since 06/21/24 | -14.33% since 06/21/24 | +37.32% since 06/21/24 | +32.16% since 06/21/24 | -13.54% since 06/21/24 |
| Low | 209.23 on 06/24/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 304.39 on 10/17/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 31,246,938 | 141,908,720 | 116,782,440 | 116,401,248 | 104,368,768 |
| Shares Outstanding, K | 128,981 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 500,920,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -111,570,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.32 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 10/31/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 10/31/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |